Overhaul Call For Outdated EU Innovation Incentives
Executive Summary
Tying supplementary protection certificates to the price of a product and replacing data exclusivity with data compensation are just two suggestions from a new paper on how EU incentives for pharmaceutical innovation should be overhauled.